Procter & Gamble Health Limited

PGHL

INE199A01012

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:50 2024-04-26 am EDT			5-day change	1st Jan Change
4,724 ^INR	+0.08%		+0.57%	-4.48%

Feb. 06	Procter & Gamble Health Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024	CI
Feb. 06	Procter & Gamble Health Limited Declares Special Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024	CI

Procter & Gamble Health Limited Announces Resignation of Amit Gupta as Chief Financial Officer, Effective March 31, 2023

March 17, 2023 at 01:11 am EDT

Procter & Gamble Health Limited announced that Mr. Amit Gupta has tendered his resignation as Chief Financial Officer of the Company effective close of business hours of March 31, 2023. Mr. Amit Gupta will be moving to a regional role within the Procter & Gamble Group.

Latest news about Procter & Gamble Health Limited

Procter & Gamble Health Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024	Feb. 06	CI
Procter & Gamble Health Limited Declares Special Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024	Feb. 06	CI
Procter & Gamble Health Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 06	CI
Procter & Gamble Health Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 03	CI
Procter & Gamble Hygiene to Discontinue Injection Production at Goa, Unit, India	23-09-27	MT
Procter & Gamble Health Limited Discontinues Production of Injections at its Manufacturing Plant in Goa Effective September 30, 2023	23-09-27	CI
Procter & Gamble Health's Net Profit Slumps in Fiscal Q4; Shares Dip 5%	23-08-24	MT
Procter & Gamble Health Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-23	CI
Procter & Gamble Health Limited Reports Earnings Results for the Fourth Quarter Ended June 30, 2023	23-08-23	CI
Procter & Gamble Health Limited Recommends Final Dividend,Payable Between November 28, 2023 to December 18, 2023	23-08-23	CI
Procter & Gamble Health Limited Announces Change in Senior Management Personnel	23-07-31	CI
Procter & Gamble India to invest $244 million to set up manufacturing facility	23-06-29	RE
Procter & Gamble Health Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
Procter & Gamble Health Appoints CFO	23-03-17	MT
Procter & Gamble Health Limited Appoints Lokesh Chandak as Chief Financial Officer, Effective April 1, 2023	23-03-17	CI
Procter & Gamble Health's CFO Resigns	23-03-17	MT
Procter & Gamble Health Limited Announces Board Changes	23-03-17	CI
Procter & Gamble Health Limited Announces Resignation of Amit Gupta as Executive Director, Effective March 31, 2023	23-03-17	CI
Procter & Gamble Health Limited Announces Resignation of Amit Gupta as Chief Financial Officer, Effective March 31, 2023	23-03-17	CI
Procter & Gamble Health Limited Recommends an Interim Dividend for the Financial Year 2022-23, Payable on or Before March 05, 2023	23-02-05	CI
Procter & Gamble Health Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-05	CI
Procter & Gamble Health Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-11	CI
Procter & Gamble Health Limited Announces Intimation of Shifting of the Registered Office	22-09-14	CI
Procter & Gamble Health Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-29	CI
Procter & Gamble Health's Fiscal Q4 Profit Climbs to $5 Million	22-08-29	MT

Chart Procter & Gamble Health Limited

Duration

Period

More charts

Company Profile

Procter & Gamble Health Limited is an India-based company that is primarily engaged in the manufacturing of pharmaceutical products. The Company is engaged in the manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Companyâs brands include Cosome, Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Evion range has different variants with different levels of Vitamin E, such as Evion 400, Evion 200, and Evion 600. Neurobion offers a range of neurotropic B-Vitamins which are a combination to help treat nerve damage and regenerate the nerves to relieve symptoms. Nasivion Classic Nasal Spray starts working on a blocked nose in 25 seconds. Polybion is a brand that helps with release and hence supports an active life.

Sector

Pharmaceuticals

Calendar

2024-05-01 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
PROCTER & GAMBLE HEALTH LIMITED	-4.48%	940M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+10.86%	14.09B
CIPLA LIMITED	+13.07%	13.64B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B

Generic Pharmaceuticals